Ê×Ò³ > ÎÄ´«ÉÌѶ > ÕýÎÄ |
|
|
ÐÂÖ¤¾Ý֤ʵEPA¿É¸ß¶ÈÔ¤²âֲƤʧ°Ü£¬Ö§³ÖSystagenix´²±ß¼ìÑéWOUNDCHEK Protease StatusµÄЧÓÃ
À´Ô´:Â¿Æ¤Íø ×÷Õß:ØýÃû 2013-5-21Ó¢¹ú¸ÇÌØÍþ¿Ë--(ÃÀ¹úÉÌÒµ×ÊѶ)--Ñо¿ÈËÔ±·¢ÏÖµÄÐÂÖ¤¾Ý½Òʾ£¬½ü°ëÊýֲƤʧ°ÜµÄÉË¿Ú(43%)±»¼ì²â³öµ°°×ø»î¶¯ÐÔÉý¸ß(EPA)1£¬ÕâÒ»ÐÂÖ¤¾ÝÓÚ2013Äê5ÔÂ15ÈÕ£¨ÖÜÈý£©Ôڸ籾¹þ¸ùÕÙ¿ªµÄÅ·ÖÞÉ˿ڴó»á(EWMA)»áÒéÉϽøÐгʱ¨¡£
´ËÏî30Àý»¼Õß²ÎÓëµÄÑо¿ÊÇÓÉ·¨¹úÄÏÌØ´óѧҽԺ(University Hospital, Nantes)Õû¸´ºÍÃÀÈÝÍâ¿Æ²¿Ö÷ÈΡ¢Ò½Ñ§²©Ê¿Franck Duteille½ÌÊÚÖ÷³Ö½øÐе쬏ÃÏîÑо¿±íÃ÷£¬¶ÔÓÚֲƤÊÖÊõǰ¼ì²â³öEPAÑôÐÔµÄÉ˿ڣ¬ËÄ·ÖÖ®Èý(75%)µÄ´ËÀàÉ˿ڳöÏÖºñ¶ÈÁÑ¿ªÖ²Æ¤Ê§°Ü1¡£ÕâÒ»½á¹û֤ʵÁËEPA¿É×÷Ϊ¸ß¶ÈÔ¤²â±êÖ¾Î°ïÖúÍâ¿ÆÒ½Éú¸ü¼ÓÓÐЧµØÊµÊ©Ö²Æ¤ÊÖÊõ£¬´Ó¶øÌá¸ßÆäÊÖÊõ³É¹¦ÂÊ¡£
SystagenixÈ«ÇòÓªÏú¸±×ܲÃPaolo Di VincenzoÆÀÂÛµÀ£º¡°SystagenixµÄWOUNDCHEK™ Protease StatusÊÇĿǰΨһÊÐÊ۵Ŀɼì²âEPAµÄ´²±ß¼ìÑ鹤¾ß¡£²»¶ÏÓÐÑо¿ÏÔʾ£¬ÀûÓÃWOUNDCHEK™ Protease StatusÐÖú½øÐеÄEPA¼ì²â¿É°ïÖúÖ¸µ¼ÖÎÁÆ£¬²¢Ìá¸ß³É¹¦ÂÊ¡£ÔÚDuteille½ÌÊÚ½øÐеÄÑо¿ÖУ¬96%µÄ³É¹¦ÒÆÖ²¾ßÓнϵ͵ĵ°°×ø»î¶¯ÐÔ¡£¶ø¶ÔÓÚÄÇЩʧ°ÜµÄÒÆÖ²£¬¼¸ºõ°ëÊýÓëEPAÏà¹Ø¡£Ö²Æ¤ÊÖÊõµÄ»¨·Ñ¸ß´ï6,000Å·Ôª2£¬È»¶øÓдóÁ¿»¼ÕßÊõºó³öÏÖ²»ÊÊ£¬ÇÒÒÆÖ²Ê§°ÜÂʼ«¸ß¡£Í¨¹ý²ÉÓÃWOUNDCHEK™ Protease Status½øÐÐEPA¼ì²â£¬Íâ¿ÆÒ½Éú±ãÓпÉÄܱÜÃ⼸½ü°ëÊýµÄֲƤÊÖÊõʧ°Ü£¬´Ó¶øÌá¸ßËûÃǵÄÊÖÊõ³É¹¦ÂÊ£¬²¢¿É½ÚÊ¡´óÁ¿×ÊÔ´ºÍ×ʽ𣬻¹¿É±ÜÃâÊÜÓ°Ï컼Õß²úÉúʧÍû´ì°ÜÇéÐ÷¡£¡±
ºÜ¾ÃÒÔÀ´£¬ÁÙ´²Ò½ÉúÒ»Ö±»³Òɵ°°×ø»î¶¯ÐԿɶÔֲƤÊõÔì³É²»ÀûÓ°Ï죬ÕýÈç½üÆÚ·¢±íµÄÒ»·ÝÓйØÕâÒ»Ö÷ÌâµÄ¹²Ê¶ÐÔ³ö°æÎïÖÐËùÊö£º¡°ÓÉÓÚEPAÒѱ»È·ÈÏΪ¿ÉÄÜÊÇÔì³ÉÒÆÖ²Ê§°ÜµÄÒ»ÏîÒòËØ£¬ÎªÁËÌá¸ßÊÖÊõ³É¹¦ÂÊ£¬¿ÉÒÔÔÚֲƤÊÖÊõ֮ǰ½øÐд²±ßµ°°×ø»î¶¯ÐÔ¼ì²â¡£¡±3
SystagenixÊǼÌÊÕ¹ºÁËÇ¿Éú¹«Ë¾µÄרҵÉ˿ڻ¤ÀíÒµÎñÖ®ºóÓÚ2008Äê³ÉÁ¢µÄ£¬¹«Ë¾100%ÖÂÁ¦ÓÚÉ˿ڻ¤Àí£¬¿ª·¢ºÍÓªÏúÏȽøµÄÉË¿ÚÕï¶ÏºÍÖÎÁƽâ¾ö·½°¸£¬ÆäÏȽøµÄ´´¿Ú·óÁÏÈ«ÇòÔ¹©»õÁ¿³¬¹ý2000ÍòƬ¡£
WOUNDCHEK™ Protease StatusĿǰûÓлñµÃFDAºË×¼ÔÚÃÀ¹úÊг¡ÏúÊÛ¡£
- Íê -
1. Duteille FµÈ, Evaluation of the use of a point of care test for proteases to identify patients with increased risk of skin graft failure£¨ÆÀ¹ÀʹÓõ°°×ø´²±ß¼ìÑ鷨ʶ±ðÃæÁٽϸßֲƤʧ°Ü·çÏյϼÕߣ©, 2013 EWMA»áÒéǽչ±¨¸æ
2. DRG case value (J08B) = cost weight (1,979) x base rate (2.991,53 € BBFW2012)£¨µÂ¹ú£©[DRG²¡Àý¼Û¸ñ(J08B) = ³É±¾È¨ÖØ(1,979) x »ù±¾·ÑÂÊ(2.991,53 € BBFW2012)]
3. Die Rolle eines Proteasen Schnelltests in der Wunddiagnostik£¨µ°°×øËÙ¼ìÔÚÉË¿ÚÕï¶ÏÖеÄ×÷Óã©. (2012) Wund Management£¨É˿ڻ¤Àí£©.
ÃâÔðÉùÃ÷£º±¾¹«¸æÖ®ÔÎİ汾Ä˹ٷ½ÊÚȨ°æ±¾¡£ÒëÎĽö¹©·½±ãÁ˽âÖ®Ó㬷³Çë²ÎÕÕÔÎÄ£¬ÔÎİ汾ÄËΨһ¾ß·¨ÂÉЧÁ¦Ö®°æ±¾¡£
ÁªÏµ·½Ê½£º
VSPR£¨´ú±íSystagenix£©
Vicky Stoakes
+44 (0)7747 534 519
vicky@vs-pr.com
[£«ÊÕ²Ø] |
CNHÀûÓÃ×îаæMentor Graphics CapitalºÍVeSysÈí¼þÔöÇ¿¡
DVS Sciences CyTOF´óÁ¿Ï¸°û¼ÆÊýÒDZ»Cytometry A 2012¡
Åí²©ÈÎÃüSamuel Palmisanoµ£ÈζÀÁ¢¹ËÎÊ
GEÒ½ÁƼ¯ÍÅÍÆ³ö#GetFit°©Ö¢Ô¤·À»î¶¯
Ô½À´Ô½¶àµÄÆóҵͨ¹ýDocuSignʵÏÖÒµÎñÊý×Ö»¯£¬´ÙʹDocu¡